Basel Medical Group Ltd (NASDAQ:BMGL – Free Report)’s stock is going to reverse split before the market opens on Monday, June 22nd. The 1-12 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the closing bell on Sunday, June 21st.
Basel Medical Group Stock Performance
BMGL stock opened at $0.59 on Friday. Basel Medical Group has a 52-week low of $0.38 and a 52-week high of $4.85. The stock’s 50 day moving average is $0.62 and its two-hundred day moving average is $0.68.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings downgraded Basel Medical Group from a “sell (d-)” rating to a “sell (e+)” rating in a report on Friday, May 29th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock has an average rating of “Sell”.
Institutional Investors Weigh In On Basel Medical Group
Several hedge funds and other institutional investors have recently bought and sold shares of the business. Marex Group plc purchased a new stake in Basel Medical Group during the 2nd quarter worth approximately $25,000. Virtu Financial LLC grew its position in shares of Basel Medical Group by 108.8% in the 3rd quarter. Virtu Financial LLC now owns 33,786 shares of the company’s stock worth $61,000 after acquiring an additional 17,608 shares in the last quarter. Finally, Citadel Advisors LLC acquired a new position in shares of Basel Medical Group in the 3rd quarter worth approximately $169,000.
Basel Medical Group Company Profile
Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.
Further Reading
- Five stocks we like better than Basel Medical Group
- Time to Sell? 3 Winners With Fading Technical Momentum
- Why These 2 Hotel Stocks Are Beating Travel Peers
- This Energy Stock Has Quietly Soared 130% in a Year
- 3 ‘Boring’ Dividend Stocks With Tasty Technical Setups
Receive News & Ratings for Basel Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Basel Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.
